Department of Surgery, Hospital of Helsingborg
Helsingborg, Skåne County, Sweden
NCT Number: NCT07298980
The study is a randomized trial designed to examine whether an "expressive writing" intervention can affect the quality of life in patients recently diagnosed with breast cancer. The method "expressive writing" consists of writing about the breast cancer or other related subjects during 20 minutes, once a week for four consecutive weeks. The impact on quality of life will be assessed by having participants complete questionnaires at three different time points during the study. The questionnaire will be developed using a clinimetric approach, based on semi-structured interviews with breast cancer patients. The themes emerging from these interviews will be used to formulate the questions. Additionally, well-known quality-of-life measurement instruments and registry data with clinically relevant information-such as tumor stage and treatment-will be incorporated.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Helsingborg, Skåne County, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Expressive writing means that the patient writes privately about the cancer or other related subject for 20 minutes. This will be repeated once a week for 4 weeks. The writing should be done in a place free from distractions and on the patients' mother tongue. The text will not be collected.
Time frame: At the 12 months follow-up
According to EQ-5D-5L VAS. The scale ranges from 0-100 where 0 is "worst possible health" and 100 is "best possible health".
Region Skane
Other
Expressive Writing in Breast Cancer - The ExBRAC Trial
Acronym: ExBRAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07328516
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03762733
Adnexal Diseases, Breast Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT07651345
Breast Cancer, Breast Diseases
Singapore
View Trial DetailsNCT07644845
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial Details